Informing Neurology Through Play

Our Inspiring Brand


TeleHaptics Care for Neurology

Learn More

hapticsEM™ by AuraSense Prototype

Our Founders

David Charlot, PhD, MSEng

CEO & Founder

Amber Ivey, JD, MPA

Chief Strategist & Co-Founder


Maryam Saleh, PhD

Innovation & Entrepreneurship

Sara Myers, PhD


Claudio Pacchierotti, PhD

Haptics & Robotics

Our Partners

Our Journey

Started in the Summer of 2022

Showcasing for DoD

Used opportunity to refine product messaging for AuraSense products at NSIN DES in August 2022.

A Competitive Start

Executive Chairman, Head of Product, and co-Founder Dr. David Charlot participated in the CRANE IP Pitch Competition placing 2nd. Wins $4K to get the company started.

Demo Day Graduation

One of 6 teams showcasing at NSIN Foundry 2022 Demo Day in September 2022. Took home the $20K prize to accelerate company product development.

Showcasing at Cade

Showcased our early prototype as joyful finalists for the 2022 CADE Fibonacci Prize.

TechCrunch Disrupt 2022

Showcased our early prototype Oct 18-21 in SF.

A 4 Minute Quick Pitch at Black Men Talk Tech

Dr. Charlot, wins 2nd Place at BMTT in Miami in October 2022.

AR + Haptics

Team AuraSense showcases early prototype with partners Lenovo and Phibonacci at CES 2023.

Interviewing Dr. Sara Myers about XR and Healthcare

Dr. Charlot interviews industry expert Dr. Sara Myers at VRARA Healthcare Summit October 31, 2022.

Vegas with Love

Showcased early AuraSense prototype at CES 2023 in Las Vegas.

Joining AARP

Excited to join AARPs AgeTech Collaborative to explore AuraSense's product value. Met the Age Collaborative Team in Vegas.

A Trip to Lake Nona, FL

Team AuraSense showcased at the annual Lake Nona Impact Forum hosted by KPMG in March 2023

A New Home

AuraSense joins mHUB in Chicago to accelerate development of our first product in March 2023

TechCrunch 2023

Showcasing our hardware development progress from mHUB at TechCrunch Disrupt 2023. Honored to be in the Battlefield 200


AuraSense joins HAX in Newark, NJ in September 2023 to sprint through hardware development for upcoming Q2 2024 validation studies